Citizens Financial Group Inc Regeneron Pharmaceuticals, Inc. Transaction History

Citizens Financial Group Inc

$4.91 Billion
Q3 2024

A detailed history of Citizens Financial Group Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Citizens Financial Group Inc holds 12,018 shares of REGN stock, worth $8.44 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

12,018

Previous 12,130 0.92%

Holding current value

$8.44 Million

Previous $12.7 Million 0.9%

% of portfolio

0.26%

Previous 0.29%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$1024.09 - $1201.76 $114,698 - $134,597	-112 Reduced 0.92%	12,018 $12.6 Million
Q2 2024 Aug 09, 2024	BUY	$883.2 - $1071.19 $112,166 - $136,041	127 Added 1.06%	12,130 $12.7 Million
Q1 2024 May 17, 2024	SELL	$902.69 - $993.35 $250,947 - $276,151	-278 Reduced 2.26%	12,003 $11.6 Million
Q4 2023 Feb 02, 2024	SELL	$775.18 - $881.7 $19,379 - $22,042	-25 Reduced 0.2%	12,281 $10.8 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $272,825 - $332,681	-394 Reduced 3.1%	12,306 $10.1 Million
Q2 2023 Aug 04, 2023	BUY	$700.03 - $830.35 $52,502 - $62,276	75 Added 0.59%	12,700 $9.13 Million
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $222,520 - $270,419	-327 Reduced 2.52%	12,625 $10.4 Million
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $571,065 - $620,009	-809 Reduced 5.88%	12,952 $9.34 Million
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $573 - $724	-1 Reduced 0.01%	13,761 $9.48 Million
Q2 2022 Aug 05, 2022	SELL	$548.35 - $738.84 $100,348 - $135,207	-183 Reduced 1.31%	13,762 $8.14 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $107,716 - $126,415	-181 Reduced 1.28%	13,945 $9.74 Million
Q4 2021 Feb 10, 2022	SELL	$543.48 - $670.97 $136,413 - $168,413	-251 Reduced 1.75%	14,126 $8.92 Million
Q3 2021 Nov 05, 2021	SELL	$574.03 - $680.96 $194,022 - $230,164	-338 Reduced 2.3%	14,377 $8.7 Million
Q2 2021 Aug 04, 2021	BUY	$472.8 - $558.54 $6.96 Million - $8.22 Million	14,715 New	14,715 $8.22 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $34,319 - $41,467	-63 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $17,759 - $23,181	36 Added 133.33%	63 $39,000
Q1 2020 May 08, 2020	BUY	$336.18 - $494.43 $3,361 - $4,944	10 Added 58.82%	27 $13,000
Q4 2019 Feb 07, 2020	BUY	$274.13 - $376.51 $4,660 - $6,400	17 New	17 $6,000
Q3 2019 Nov 01, 2019	SELL	$273.46 - $318.39 $1,914 - $2,228	-7 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$299.6 - $414.82 $19,474 - $26,963	-65 Reduced 90.28%	7 $2,000
Q1 2019 May 09, 2019	BUY	$372.08 - $439.57 $26,789 - $31,649	72 New	72 $30,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.

Account

Citizens Financial Group Inc Regeneron Pharmaceuticals, Inc. Transaction History